Stuttgart - Delayed Quote EUR
Bio-Rad Laboratories Inc (BUWA.SG)
214.10
+5.10
+(2.44%)
As of 8:01:21 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,541,100
2,566,500
2,671,200
2,802,200
2,922,545
Cost of Revenue
1,182,100
1,187,600
1,244,300
1,234,900
1,284,449
Gross Profit
1,359,000
1,378,900
1,426,900
1,567,300
1,638,096
Operating Expense
1,110,900
1,109,900
1,089,100
1,092,200
1,137,760
Operating Income
248,100
269,000
337,800
475,100
500,336
Net Non Operating Interest Income Expense
35,600
33,100
51,500
20,000
17,349
Other Income Expense
-3,033,900
-2,644,600
-1,239,400
-5,199,300
4,931,395
Pretax Income
-2,750,200
-2,342,500
-850,100
-4,704,200
5,449,055
Tax Provision
-586,100
-498,300
-212,800
-1,076,700
1,194,798
Net Income Common Stockholders
-2,164,100
-1,844,200
-637,300
-3,627,500
4,254,257
Diluted NI Available to Com Stockholders
-2,164,100
-1,844,200
-637,300
-3,627,500
4,254,257
Basic EPS
-76.53
-65.36
-21.82
-121.79
142.33
Diluted EPS
-76.53
-65.36
-21.82
-121.79
140.56
Basic Average Shares
28,069.75
28,214
29,209
29,785
29,831
Diluted Average Shares
28,069.75
28,214
29,209
29,785
30,208
Total Operating Income as Reported
248,100
269,000
337,800
482,600
500,336
Total Expenses
2,293,000
2,297,500
2,333,400
2,327,100
2,422,209
Net Income from Continuing & Discontinued Operation
-2,164,100
-1,844,200
-637,300
-3,627,500
4,254,257
Normalized Income
224,263.14
238,359.40
294,050
382,933.60
403,384.21
Interest Income
84,200
82,000
100,900
58,100
18,900
Interest Expense
48,600
48,900
49,400
38,100
1,551
Net Interest Income
35,600
33,100
51,500
20,000
17,349
EBIT
-2,701,600
-2,293,600
-800,700
-4,666,100
5,450,606
EBITDA
-2,549,000
-2,142,000
-654,800
-4,528,800
5,588,206
Reconciled Cost of Revenue
1,182,100
1,187,600
1,244,300
1,234,900
1,284,449
Reconciled Depreciation
152,600
151,600
145,900
137,300
137,600
Net Income from Continuing Operation Net Minority Interest
-2,164,100
-1,844,200
-637,300
-3,627,500
4,254,257
Total Unusual Items Excluding Goodwill
-3,035,200
-2,646,200
-1,241,800
-5,201,600
4,930,695
Total Unusual Items
-3,035,200
-2,646,200
-1,241,800
-5,201,600
4,930,695
Normalized EBITDA
486,200
504,200
587,000
672,800
657,511
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-646,836.86
-563,640.60
-310,450
-1,191,166.40
1,079,822.21
12/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade